pcDNA3.1 human A3F-CTD
(Plasmid
#105052)
-
PurposeOverexpression of APOBEC3F C-terminal domain in mammalian cell lines
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 105052 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5428
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAPOBEC3F (A3F) C-terminal domain
-
SpeciesH. sapiens (human)
-
Insert Size (bp)603
-
Mutationit contains only C terminal domain of A3F
-
Entrez GeneAPOBEC3F (a.k.a. A3F, ARP8, BK150C2.4.MRNA, KA6)
- Promoter CMV
-
Tag
/ Fusion Protein
- HA tag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (unknown if destroyed)
- 3′ cloning site EcoRI (unknown if destroyed)
- 5′ sequencing primer 5'-CGCAAATGGGCGGTAGGCGTG
- 3′ sequencing primer 5'-TAGAAGGCACAGTCGAGG (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1 human A3F-CTD was a gift from Carsten Münk (Addgene plasmid # 105052 ; http://n2t.net/addgene:105052 ; RRID:Addgene_105052) -
For your References section:
Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1. Jaguva Vasudevan AA, Hofmann H, Willbold D, Haussinger D, Koenig BW, Munk C. J Mol Biol. 2017 Apr 21;429(8):1171-1191. doi: 10.1016/j.jmb.2017.03.015. Epub 2017 Mar 16. 10.1016/j.jmb.2017.03.015 PubMed 28315663